Integration that Performs
at Every Stage
ABEC’s Hybrid BioProcessing combines the flexibility of single-use with the long-life control of stainless steel, without sacrificing performance. Our approach focuses on seamless single-use integration within hybrid facilities, ensuring that our disposable CSR® technologies are fully aligned with stainless steel infrastructure, automation, and process control from the outset.
Through an integrated project delivery model, we help biopharma manufacturers scale efficiently, reduce operational risk, and maintain consistent performance as pipelines evolve. ABEC remains uniquely positioned in the industry as a supplier capable of delivering both single-use and stainless steel process platforms for commercial manufacturing. This dual capability allows us to provide an objective, technology-neutral perspective when recommending solutions – ensuring that the selected approach aligns with your process requirements, operational strategy, and long-term manufacturing goals.
PROVEN TO DELIVER
FLEXIBILITY WITHOUT COMPROMISE
Biopharma manufacturing rarely stays static. As priorities shift, demands change, and facilities expand, you need solutions that can adapt without creating new complexities.
ABEC’s Hybrid BioProcessing solutions are engineered to balance agility and long-term productivity—integrating single-use, stainless steel, and automation into one cohesive approach. The result is a strategic system that supports multi-product operations, accelerates changeovers, and sustains performance at scale.
ONE ACCOUNTABLE PARTNER
The success of Hybrid BioProcessing depends on how well systems function together. ABEC hybrid designs are integrated systems, with engineering, fabrication, automation, validation and operation aligned from the start. That integration also means clear accountability—ABEC stands behind the solution and its successful execution. There are fewer handoffs and surprises, less rework, and a smoother path to production readiness.
PERFORMANCE CONSISTENCY
ABEC’s hybrid solutions are built to preserve process behavior across both single-use and stainless-steel operations. By engineering around process goals—mixing, mass transfer, control strategy, and scale logic—we help biopharma manufacturers maintain process consistency even as formats and goals evolve and change.
MULTI-PRODUCT REALITY
ABEC’s hybrid environments support product diversity and facility utilization. Our single-use system performance and scale allow a wide range of production capacities to be realized. Our system design and layout expertise allow plants to be configured to facilitate campaign changeover, allowing you to achieve a true multi-product facility.
LIFECYCLE SUPPORT
The needs of hybrid facilities can evolve quickly. ABEC’s service and support programs help keep your operations optimized to your current process—supporting upgrades, retrofits, and expansion without disrupting ongoing production. Investing in an ABEC solution goes beyond a one-time transaction. Our Customer Experience team remains engaged throughout the lifecycle of your equipment, ensuring continued performance, responsiveness, and support as your facility evolves.
FLEXIBLE MANUFACTURING PLATFORM (FMP)
Investing in new manufacturing capacity can be an enormous risk. Limited patent windows drive the need for immediate production capacity once novel therapies are approved, but market demand can be difficult to predict so far in advance of product release. ABEC FMP serves as a way to mitigate those risks. Using all of the strengths of both single use and stainless steel, ABEC can evaluate your business divers and develop a roadmap for expansion that matches your regulatory and production schedule. The FMP is a hybrid, modular, integrated plant design that can scale production capacity when the right market conditions are met.
A ONE-SYSTEM APPROACH
Hybrid BioProcessing should be a platform for growth, not a source of complexity. ABEC fully integrates capabilities from process sciences and automation to engineering, system and vessel fabrication, and support services, ensuring that our hybrid solutions perform precisely as intended.
ABEC develops hybrid manufacturing platforms through a structured assessment that considers all the key variables. Our evaluation begins with a review of your business goals, process characteristics, production volumes, facility strategy, and anticipated product lifecycle to determine the most appropriate technology platform. The evaluation typically considers Cost of Goods Sold, operational efficiency, productivity and throughput. quality and product consistency, flexibility and scalability, time to market, sustainability and environmental Impact, and risk management.
Based on this structured analysis, ABEC provides a technology-neutral recommendation that balances lifecycle economics, operational performance, regulatory compliance, and long-term manufacturing strategy to support your customer’s specific program and facility objectives.